🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this Phase II follow-up study (to study 810501) is to assess...
Status
Completed
Location
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna
Start Date
2007-09
Trial ID
NCT00530660
Treatments Being Tested
This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Status
Completed
Location
Hôpital Général de Référence de Boende
Start Date
2019-12-18
Trial ID
NCT04186000
Treatments Being Tested
The success of the U.S. vaccination program against SARS-Cov-2 is shown by ...
Status
Terminated
Location
Griffin Hospital
Start Date
2021-10-15
Trial ID
NCT05081271
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
The purpose of this study is to determine the safety of and immune response...
Status
Completed
Location
Alabama Vaccine CRS
Start Date
2007-08
Trial ID
NCT00472719
Treatments Being Tested
PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Status
Completed
Location
National Centre for Infectious Diseases (NCID)
Start Date
2021-10-12
Trial ID
NCT05142319
Treatments Being Tested
This is a randomized, phase II trial which will be conducted among voluntee...
Status
Unknown
Location
National Institute of Health
Start Date
2022-03-01
Trial ID
NCT05162482
Treatments Being Tested
The goal of this clinical trial is to assess the immunogenicity and safety ...
Status
Unknown
Location
Chengdu Xinhua Hospital Affiliated to North Sichuan Medical College
Start Date
2022-05-14
Trial ID
NCT05928455
This is an open-label, non-randomized, single-center, dose-escalation Phase...
Status
Recruiting
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2026-04-21
Trial ID
NCT07417488
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, dose-escalation s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05609045
Treatments Being Tested